Skip to main content
Premium Trial:

Request an Annual Quote

Empire Genomics Clinical Lab Gets CLIA Certification, New York Approval

NEW YORK (GenomeWeb News) – Empire Genomics today said that its clinical laboratory facility has received CLIA certification and has been approved by the New York State Department of Health.

As a result, Buffalo, New York-based Empire Genomics said it plans to offer assays based on biomarkers for myeloma and prostate cancers in 2014. The company licensed a genomic biomarker from Emory University in late 2012 for multiple myeloma to develop a companion diagnostic, and in May the firm was awarded a Small Business Innovation Research grant from the National Cancer Institute to develop the test.

In May also, it licensed a biomarker from Cornell University to develop a companion diagnostic for neuroendocrine prostate cancer, and in June, Empire Genomics, the University of Buffalo, and Life Technologies joined forces to develop CLIA-certified next-generation sequencing facilities in upstate New York.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.